Viatris (VTRS) News Today $11.32 -0.01 (-0.09%) (As of 10/8/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Is Viatris Inc. (NASDAQ:VTRS) The Best NASDAQ Stock Under $20?October 8 at 1:59 PM | msn.comViatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a RowOctober 8 at 11:00 AM | prnewswire.comNovo Nordisk, Viatris settle patent dispute over Ozempic, Wegovy: reportOctober 7 at 10:57 PM | seekingalpha.comNovo Nordisk (NYSE:NVO) and Viatris Settle Patent Dispute for Weight-Loss DrugsOctober 7 at 10:57 PM | msn.comViatris Inc. (VTRS.VI)September 21, 2024 | sg.finance.yahoo.comVTRS Oct 2024 16.000 callSeptember 21, 2024 | ca.finance.yahoo.comVTRS Jan 2025 20.000 callSeptember 21, 2024 | ca.finance.yahoo.comViatris Announces the Pricing Terms of Maximum Tender OfferSeptember 18, 2024 | prnewswire.comViatris Announces Early Tender Results and Increase of Pending Maximum Tender OfferSeptember 17, 2024 | prnewswire.comDo Options Traders Know Something About Viatris (VTRS) Stock We Don't?September 16, 2024 | msn.comViatris to Report Third Quarter 2024 Financial Results on November 7, 2024September 16, 2024 | prnewswire.comViatris 2023 Sustainability Report: Advocating for PatientsSeptember 12, 2024 | finanznachrichten.deViatris Announces Expiration and Results of Any and All Cash Tender OffersSeptember 10, 2024 | prnewswire.comViatris Inc.: Viatris Announces the Pricing Terms of Pending Any and All Cash Tender OffersSeptember 10, 2024 | finanznachrichten.deViatris Announces the Pricing Terms of Pending Any and All Cash Tender OffersSeptember 10, 2024 | prnewswire.comViatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy EngagementSeptember 9, 2024 | stockhouse.comViatris Announces Cash Tender Offers for Certain Outstanding NotesSeptember 4, 2024 | prnewswire.comViatris Q2 Earnings TranscriptAugust 29, 2024 | marketbeat.comViatris Inc. (VIA.F)August 27, 2024 | uk.finance.yahoo.comViatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual CongressAugust 23, 2024 | prnewswire.com3 Top Value Stocks to Buy Right NowAugust 20, 2024 | fool.comVTRS Sep 2024 12.000 callAugust 18, 2024 | ca.finance.yahoo.comVTRS Sep 2024 9.000 putAugust 17, 2024 | ca.finance.yahoo.comWhy Bargain-Priced Viatris Could Deliver Strong ReturnsAugust 15, 2024 | seekingalpha.comAnalyst Maintains Sell Rating on Viatris Citing Long-Term Revenue Concerns and Growth ChallengesAugust 9, 2024 | markets.businessinsider.comViatris hits seven-month high after Q2 beatAugust 8, 2024 | msn.comWhy Viatris Stock Is Jumping TodayAugust 8, 2024 | fool.comViatris Sees 2024 Revenue Growth Of Approx. 2% On Divestiture-adj. Operational Basis - UpdateAugust 8, 2024 | markets.businessinsider.comViagra-maker Viatris beats Q2 estimates on branded and generic drug demandAugust 8, 2024 | reuters.comViatris Reports Second Quarter Financial Results for 2024August 8, 2024 | prnewswire.comWhat Wall Street expects from Viatris's earningsAugust 7, 2024 | markets.businessinsider.comValidea Detailed Fundamental Analysis - VTRSAugust 7, 2024 | nasdaq.comViatris Inc (VTRS) Q2 2024 Earnings Report Preview: What To ExpectAugust 7, 2024 | finance.yahoo.comViatris Q2 Earnings Preview: Another revenue miss in the cards?August 7, 2024 | msn.comNovartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment DrugsAugust 6, 2024 | msn.comViatris declares $0.12 dividendAugust 6, 2024 | msn.comViatris Announces Second Quarter 2024 DividendAugust 6, 2024 | prnewswire.comNovartis, Viatris face new lawsuit over 'HeLa' cell misuse claimsAugust 6, 2024 | msn.com3 Surprisingly Underrated Stocks to Buy Right NowJuly 26, 2024 | fool.comViatris Inc (VTRS:NAS) Company Profile: Analytics, Extensive Financial Metrics, and Benchmark Against Averages and Top Companies Within its IndustryJuly 26, 2024 | globenewswire.comIdorsia announces financial results for the first half 2024July 25, 2024 | globenewswire.comBig pharma rally after J&J earningsJuly 19, 2024 | msn.comViatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business DivestitureJuly 3, 2024 | prnewswire.comUS DOJ drops Viatris unit Mylan from industry-wide antitrust probeJuly 2, 2024 | reuters.comU.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust InvestigationJuly 2, 2024 | prnewswire.comViatris Named to TIME's World's Most Sustainable Companies 2024 ListJune 25, 2024 | prnewswire.comViatris: Revenues, Debt, Valuation And Strategy Under The MicroscopeJune 13, 2024 | seekingalpha.comViatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)June 11, 2024 | seekingalpha.comViatris to Report Second Quarter 2024 Financial Results on August 8, 2024June 7, 2024 | prnewswire.comViatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)June 6, 2024 | seekingalpha.com Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address [SHOCKING] Crypto Document Leak… (Ad)A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move is being made in preparation to onboard all of Sony products (including Sony's Playstation, which captured a record 62% share of the global gaming console market in 2024). Enthusiasts and experts are buzzing with anticipation qnd one little-known crypto coin is poised for RAPID growth as we see this all unfold. Click here to review my research and unique strategy to score potential profits from this under-the- VTRS Media Mentions By Week VTRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTRS News Sentiment▼-0.070.49▲Average Medical News Sentiment VTRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTRS Articles This Week▼43▲VTRS Articles Average Week Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Takeda Pharmaceutical News BioNTech News BeiGene News Moderna News Teva Pharmaceutical Industries News Ginkgo Bioworks News Genmab A/S News Summit Therapeutics News Dr. Reddy's Laboratories News Vaxcyte News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTRS) was last updated on 10/8/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viatris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viatris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
